Krystal Biotech Financials

Values in thousands	2026-09-30	2026-06-30	2026-03-31	2025-12-31
Revenue	$127,341	$119,222	$116,357	$107,105
Gross Profit	119,785	112,785	110,034	96,188
EBITDA	81,832	67,645	63,168	39,606
EBIT	80,145	66,079	61,442	37,844
Net Income	63,068	54,768	55,932	51,400
Net Change In Cash	127,341	119,222	116,357	107,105
Free Cash Flow	90,253	71,224	73,234	75,369
Cash	462,841	427,740	501,313	496,304
Basic Shares	30,838	30,657	30,507	29,951

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$389,130	$290,515	$50,699	$0
Gross Profit	360,357	270,454	47,605	-4,055
EBITDA	196,022	109,909	-92,220	-116,141
EBIT	189,471	103,195	-97,227	-120,196
Net Income	204,831	89,159	10,932	-139,975
Net Change In Cash	389,130	290,515	50,699	0
Free Cash Flow	188,914	119,182	-100,603	-153,548
Cash	496,304	344,865	358,328	161,900
Basic Shares	29,951	29,740	27,752	25,492